Result Update:Gravita India
Axis Direct
We maintain our BUY recommendation on the stock.
Broker Research reports: Maximum gain potential
for all stocks
- This broker has downgraded this stock from it's previous report. (eg. - Buy->Hold)
- Broker has maintained previous recommendation but reduced share price target.
- This broker has upgraded this stock from it's previous report.(eg. - Sell->Hold)
- Broker has maintained previous recommendation but increased share price target.
RESEARCH REPORTS ALERTS
Load latest
Google or static link led you to an intermediate page.
- All Recent
- Upside
- Buy
- Sell
- Recent Upgrades
- Recent Downgrades
- IPO
- Sector Updates
- Most Recent
- Top Upside
Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.
| Summary | Date | Stock | Author | LTP | Target | Price at reco (Change since reco%) |
Upside(%) | Type | Report | Discuss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 06 May 2025 | Gravita |
Axis Direct
|
1657.70 | 2600.00 | 1870.80 (-11.39%) | 56.84 |
Buy
|
||||
| 23 Jul 2025 | Zee Entertainment |
ICICI Securities Limited
|
116.65 | 185.00 | 128.62 (-9.31%) | 58.59 |
Buy
|
Ad weakness persists, standoff with DPOs impacts subscriptions; digital losses narrow
ICICI Securities Limited
ZEEL’s advertising revenue declined 9.4% QoQ/16.8% YoY, impacted by the IPL and weak FMCG spending. However, management commentary suggests early signs of stabilisation, with potential recovery supported by festive tailwinds and improving rural demand.
|
|||
| 24 Mar 2025 | Cohance Lifesciences |
BOB Capital Markets Ltd.
|
892.65 | 1405.00 | 1175.50 (-24.06%) | 57.40 |
Buy
|
||||
| 25 Mar 2025 | Cohance Lifesciences |
ICICI Securities Limited
|
892.65 | 1400.00 | 1175.50 (-24.06%) | 56.84 |
Buy
|
A distinct CDMO in the making
ICICI Securities Limited
Suven’s rapid ascendance in the CDMO space has been remarkable. It has journeyed from being a small molecule-focused CDMO to achieving eminence as one of the few CDMOs in India that offers contract manufacturing of oligonucleotides and ADCs.
|
|||
| 28 Jul 2025 | Lodha Developers |
Motilal Oswal
|
1185.00 | 1870.00 | 1203.20 (-1.51%) | 57.81 |
Buy
|
Result below est., but presales and BD momentum intact
Motilal Oswal
In 1QFY26, Lodha Developers (LODHA)’s presales were up 10% YoY to INR44.5b (12% below our estimate). Collections rose 7% YoY to INR28.8b (34% below our estimates), and OCF improved 44% YoY to INR9.5b.
|
|||
| 08 Jul 2025 | Lodha Developers |
Motilal Oswal
|
1185.00 | 1870.00 | 1374.90 (-13.81%) | 57.81 |
Buy
|
||||
| 25 Mar 2025 | Brigade Enterprises |
Motilal Oswal
|
912.25 | 1415.00 | 979.35 (-6.85%) | 55.11 |
Buy
|
Scaling up in Hyderabad and Chennai; rentals to go up after FY26
Motilal Oswal
Brigade Enterprises (BRGD) posted a 36% CAGR in presales over FY20-24 and is expected to deliver more than 24% growth during FY25-27, guided by its strong launch pipeline and scale-up in Hyderabad and Chennai.
|
|||
| 22 Jul 2025 | Bansal Wire |
Anand Rathi
|
353.40 | 550.00 | 408.40 (-13.47%) | 55.63 |
Buy
|
Volume momentum to continue; maintaining a Buy
Anand Rathi
Despite Q1 usually being sluggish for it, Bansal Wires posted record quarterly volumes (~0.104m tonnes), driven by integrating operations, a customercentric approach, presence across various end-user sectors, and innovation.
|
|||
| 19 Jun 2025 | Bansal Wire |
Anand Rathi
|
353.40 | 550.00 | 372.75 (-5.19%) | 55.63 |
Buy
|
||||
| 03 Aug 2025 | Go Fashion |
ICICI Securities Limited
|
706.30 | 1100.00 | 761.25 (-7.22%) | 55.74 |
Buy
|
||||
|
more
loading
|
|||||||||||
* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.